Scoring systems in dermatology

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 4, 2006, Pages 315-321

  Bhor, Urmila ^a   Pande, Sushil ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CHLOASMA; CLINICAL PRACTICE; CLINICAL RESEARCH; DERMATOLOGY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG MONITORING; HIRSUTISM; PEMPHIGUS VULGARIS; POMPHOLYX; PSORIASIS; SCLERODERMA; SCORING SYSTEM; SKIN DISEASE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VITILIGO;

EID: 33746931583     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.26722     Document Type: Article

References (31)

1. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: The SCORAD Index. Dermatology 1993;186:23-31.
2. Jones B. Six area, six sign atopic dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996;135:25-30.
3. Van Joost TH, Heule F, Korstanje M, Van den Broek MJ, Stenveld HJ, Van Vloten WA. Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. Br J Dermatol 1994;130:634-40.
4. Bahmer FA, Schubert HJ. Quantification of the extent and severity of atopic dermatitis: The ADASI score. Arch Dermatol 1991;127:1239-40.
5. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000;136:763-9.
6. Costa C, Rilliet A, Nicolet M, Saurat JH. Scoring atopic dermatitis: The simpler the better? Acta Derm Venereol (Stockh) 1989;69:41-5.
7. Van Leent EJ, Gräber M, Thurston M, Wagenaar A, Spuls PI, Bos JD. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998;134:805-9.
8. Charman D, Varigos G, Horne DJ, Oberklaid F. The development of a practical and reliable assessment measure for atopic dermatitis (ADAM). J Outcome Meas 1999;3:21-34.
9. Cherill R, Graeber M, Hanifin J, Omoto M, Thurston M, Tofte S. Eczema area and severity index (EASI): A new tool to evaluate atopic dermatitis [abstract]. J Eur Acad Dermatol Venereol 1998;11:48.
10. Fredriksson T, Pettersson U. Severe psoriasis - Oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
11. Sugai J, Ozawa A, Kawakubo Y, Izuka M, Miyahara M, Okhido M. New method for determining prognosis of patients with psoriasis (E-PAP). J Dermatol Sci 1998;16:165-9.
12. Kirby B, Fortune DG, Bhushan M, Chalmers RJ, Griffiths CE. The Salford Psoriasis Index: An holistic measure of psoriasis. Br J Dermatol 2000;142:728-32.
13. Fleischer AB Jr, Rapp SR, Reboussin DM, Vanarthos JC, Feldman SR. Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol 1994;102:967-9.
14. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: A Serverity-of-Illness Score for Toxic Epidermal Necrolysis. J Invest Derm 2000;115:149-53.
15. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: The Vitiligo Area Scoring Index. Arch Dermatol 2004;140:677-83.
16. Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in Vitiligo Vulgaris. Arch Dermatol 1999;135:407-13.
17. Pope JE, Baron M, Belamy M, Campbell J, Carette S, Chalmers I, et al. Variability of skin scores and clinical measurements in scleroderma. J Rheumatol 1995;22:1271-6.
18. Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin Score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990;33:1256-63.
19. Clements P, Lachenbruch P, Seibold J, White G, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
20. Silman A, Harrison M, Brennan P. Is it possible to reduce observer variability in skin score assessment of scleroderma. J Rheumatol 1995;22:1277-80.
21. Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986;4:367-9.
22. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol 1961;21:1440-7.
23. Agarwal M, Walia R, Kochar AM, Chander R. Pemphigus Area and Activity Score (PAAS) - A novel clinical scoring method for monitoring of pemphigus vulgaris patients. Int J Dermatol 1998;37:158-60.
24. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994;130:727-33.
25. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol 1979;115:571-5.
26. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-The Leeds technique. Br J Dermatol 1984;111:83-92.
27. Michaelsson G, Juhlin L, Vahlquist A. Effect of oral zinc and Vitamin A in acne. Arch Dermatol 1977;113:31-6.
28. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study. J Aller Clin Immunol 2002;110:484-8.
29. Sasmaz S, Arican O. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: A pilot study. Am J Clin Dermatol 2005;6:403-6.
30. Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, et al. National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines. part II. National Alopecia Areata Foundatin. J Am Acad Dermatol 2004;51: 440-7.
31. Vocks E, Plotz SG, Ring J. The Dyshidrotic Eczema Area and Severity Index - A score developed for the assessment of dyshidrotic eczema. Dermatology 1999;198:265-9.